The product is aimed at industries, including cosmetics, pharmaceuticals, food packaging, and general consumer goods.
1h
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company’s non ...
Amazon shares plunged in after-hours trade on Thursday, falling around 11%, as the company projected a surge of more than 50% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results